Painful and involuntary multiple sclerosis

Bibliography

• Compston A, Coles A. Multiple Sclerosis. Lancet 2008;372:1502-17
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005;58:840-6
   PubMed Web of Science ®Google Scholar
• Barkhof F, Filippi M, Miller DH, Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69
   PubMed Web of Science ®Google Scholar
• Solaro C, Messmer Uccelli M. Pharmacological management of pain in patients with multiple sclerosis. Drugs 2010;70:1245-54
   PubMed Web of Science ®Google Scholar
• Hartelius L, Svensson P. Speech and swallowing symptom associated with Parkinson's disease and multiple sclerosis: a survey. Folia Phoniatr Logop 1994;46:9-17
   PubMed Web of Science ®Google Scholar
• Logemann JA. Dysphagia: evaluation and treatment. Folia Phoniatr Logop 1995;47:140-64
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52
   PubMed Web of Science ®Google Scholar
• Tassorelli C, Bergamaschi R, Buscone S, Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. Neurol Sci 2008;29(Suppl 4):360-3
   Google Scholar
• De Pauw A, Dejaeger E, D'hooghe B, Dysphagia in multiple sclerosis. Clin Neurol Neurosurg 2002;104:345-51
   PubMed Web of Science ®Google Scholar
• Abraham SS, Yun PT. Laryngopharyngeal dysmotility in multiple sclerosis. Dysphagia 2002;17:69-74
   PubMedGoogle Scholar
• Hoppers P, Holm SE. The role of fiberoptic endoscopy in Dysphagia rehabilitation. J Head Trauma Rehabil 1999;14:475-85
   PubMedGoogle Scholar
• Calcagno P, Ruoppolo G, Grasso MG, Dysphagia in multiple sclerosis - Prevalence and prognostic factors. Acta Neurol Scand 2002;105:40-3
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Tsukada T, Ootaki S, Correspondence between food consistency and suprahyoid muscle activity, tongue pressure, and bolus transit times during the oropharyngeal phase of swallowing. J Appl Physiol 2008;105:791-9
   PubMedGoogle Scholar
• Thomas FJ, Wiles CM. Dysphagia and nutritional status in multiple sclerosis. J Neurol 1999;246:677-82
   PubMedGoogle Scholar
• American Speech-Language Hearing Association. National Outcomes Measurements System (NOMS): Adult Speech-Language Pathology Training Manual. American Speech-Language Hearing Association, Rockville (Maryland); 1998
   Google Scholar
• Restivo DA, Marchese Ragona R, Patti F, Botulinum toxin improves dysphagia associated with multiple sclerosis. Eur J Neurol 2010. [Epub ahead of print]
   Google Scholar
• DeAngelis T, Lublin F. Multiple sclerosis: new treatment trials and emerging therapeutic targets. Curr Opin Neurol 2008;21:261-71
   PubMed Web of Science ®Google Scholar
• Inagaki D, Miyaoka Y, Ashida I, Influence of food properties and body position on swallowing related muscle activity amplitude. J Oral Rehabil 2009;36:176-83
   PubMedGoogle Scholar
• Henze T. What is new in symptom management? Int MS J 2007;14:22-7
   PubMedGoogle Scholar
• Payne A. Nutrition and diet in the clinical management of multiple sclerosis. J Hum Nutr Diet 2001;14:349-57
   PubMed Web of Science ®Google Scholar
• Prosiegel M, Schelling A, Wagner-Sonntag E. Dysphagia and multiple sclerosis. Int MS J 2004;11:22-31
   PubMedGoogle Scholar
• Giusti A, Giambuzzi M. Management of Dysphagia in patients affected by multiple sclerosis: state of the art. Neurol Sci 2008;29(Suppl 4):364-6
   Google Scholar
• Schrag SP, Sharma R, Jaik NJ. Complications related to percutaneous endoscopicGastrostomy (PEG) tubes. A comprehensive clinical review. J Gastrointestin Liver Dis 2007;4:407-18
   Google Scholar
• Grasso MG, Lubich S, Guidi L, Cerebellar deficit and respiratory impairment: a strong association in multiple sclerosis? Acta Neurol Scand 2000;101:98-103
   PubMed Web of Science ®Google Scholar
• Gosselink R, Kovacs L, Decramer M. Respiratory muscle involvement in multiple sclerosis. Eur Respir J 1999;13:449-54
   PubMed Web of Science ®Google Scholar
• Fry DK, Pfalzer LA, Chokshi AR, Randomized control trial of effects of a 10-week inspiratory muscle training program on measures of pulmonary function in persons with multiple sclerosis. J Neurol Phys Ther 2007;31:162-72
   PubMedGoogle Scholar
• Aiello M, Rampello A, Granella F, Cough efficacy is related to the disability status in patients with multiple sclerosis. Respiration 2008;76:311-16
   PubMed Web of Science ®Google Scholar
• Mutluay FK, Gurses HN, Saip S. Effects of multiple sclerosis on respiratory functions. Clin Rehabil 2005;19:426-32
   PubMed Web of Science ®Google Scholar
• Gosselink R, Kovacs L, Ketelaer P, Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil 2000;81:747-51
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Eisen K, Ebers GC, Cause of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193-6
   PubMed Web of Science ®Google Scholar
• Midgard R, Albrektsen G, Riise T, Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in More and Romsdal, Norway. J Neurol Neurosurg Psychiatry 1995;58:417-21
   PubMedGoogle Scholar
• Hirst C, Swingler R, Compston DA, Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008;79:1016-21
   PubMed Web of Science ®Google Scholar
• Aboussouan LS. Respiratory disorders in neurologic disease. Cleve Clin J Med 2005;72:511-20
   PubMed Web of Science ®Google Scholar
• Chiara T, Martin AD, Davenport PW, Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary cough. Arch Phys Med Rehabil 2006;87:468-73
   PubMed Web of Science ®Google Scholar
• Olindo S, Guillon B, Helias J, Decrease in heart ventricular ejection fraction during multiple sclerosis. Eur J Neurol 2002;9:287-91
   PubMed Web of Science ®Google Scholar
• Merkelbach S, Haensch CA, Hemmer B, Multiple sclerosis and the autonomic nervous system. J Neurol 2006;253(Suppl 1):21-5
   PubMedGoogle Scholar
• Scroth WS, Tenner SM, Rappaport BA, Multiple sclerosis as a cause of atrial fibrillation and electro-cardiographic changes. Arch Neurol 1992:49:422-4
   PubMedGoogle Scholar
• Frontoni M, Fiorini M, Strano S, Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. Acta Neurol Scand 1996;93:241-5
   PubMedGoogle Scholar
• Linden D, Diehl RR, Berlit P. Subclinical autonomic disturbances in multiple sclerosis. J Neurol 1995;242:374-8
   PubMedGoogle Scholar
• Vita G, Fazio MC, Milone S, Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci 1993;120:82-6
   PubMed Web of Science ®Google Scholar
• Anema JR, Heijenbrok MW, Faes TJ, Cardiovascular autonomic function in multiple sclerosis. J Neurol Sci 1991;104:129:34
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Wolf A, Krauser M, Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance. J Neurol 1999;246:578-86
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Reiners K. Abnormal baroreflex responses in multiple sclerosis. Clin Auton Res 2005;15:419
   PubMedGoogle Scholar
• Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Int J Med Sci 2010;7:62-7
   PubMed Web of Science ®Google Scholar
• Marriott JJ, Miyasaki JM, Gronseth G, Evidence report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 2010;74:1463-70
   PubMed Web of Science ®Google Scholar
• Ziemssen T, Neuhaus O, Hohlfeld R. Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Saf 2001;24:979-90
   PubMed Web of Science ®Google Scholar
• Linden D, Diehl RR, Berlit P. Subclinical autonomic disturbances in multiple sclerosis. J Neurol 1995;242:374-8
   PubMedGoogle Scholar
• Acevedo AR, Nava C, Arriada N, Cardiovascular dysfunction in multiple sclerosis. Acta Neurol Scand 2000;10:85-8
   Google Scholar
• Flachenecker P, Reiners K, Krauser M, Autonomic dysfunction in multiple sclerosis is related to disease activity and progression disability. Mult Scler 2001;7:327-34
   PubMed Web of Science ®Google Scholar
• Saari A, Tolonen U, Paakko E, Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol 2004;115:1473-8
   PubMed Web of Science ®Google Scholar
• Moya A, Sutton R, Ammirati F, Guidelines for the diagnosis and management of syncope (version 2009): the task force for the diagnosis and management of syncope of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2631-71
   PubMed Web of Science ®Google Scholar
• Quaglia MG, Farina A, Palmery M, Chiral investigation of midodrine, a long-acting alpha-adrenergic stimulating agent. Chirality 2004;16:356-62
   PubMed Web of Science ®Google Scholar
• Wright RA, Kaufman HC, Perera R, A double-blind, dose – response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998;51:120-4
   PubMed Web of Science ®Google Scholar
• Pathak A, Raoul V, Montastruc JL, Senard JM. Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France. Eur J Clin Pharmacol 2005;61:471-4
   PubMedGoogle Scholar
• van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in CO in autonomic failure. Clin Auton Res 2000;10:35-42
   PubMed Web of Science ®Google Scholar
• Bayorh MA, Eatman D, Wang M, Indomethacin attenuates post-suspension hypotension in Sprague-Dawley rats. J Gravit Physiol 2001;8:77-83
   PubMedGoogle Scholar
• Wyller VB, Thaulow E, Amlie JP. Treatment of chronic fatigue and orthostatic intolerance with propranolol. J Pediatr 2007;150:654-5
   PubMedGoogle Scholar
• Di Girolamo E, Di Iorio C, Sabatini P, Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999;33:1227-30
   PubMed Web of Science ®Google Scholar
• Zorzon M, Zivadinov R, Monti Bragadin L, Sexual dysfunction in multiple sclerosis: a 2-year follow-up study. J Neurol Sci 2001;187:1-5
   PubMed Web of Science ®Google Scholar
• Demirkiran M, Sarica Y, Uguz S, Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler 2006;12:209-14
   PubMed Web of Science ®Google Scholar
• Tepavcevic DK, Kostic J, Basuroski ID, The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 2008;14:1131-6
   PubMed Web of Science ®Google Scholar
• Zorzon M, Zivadinov R, Bosco A, Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999;5:418-27
   PubMed Web of Science ®Google Scholar
• Nortvedt MW, Riise T, Myhr KM, Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 2001;7:231-5
   PubMed Web of Science ®Google Scholar
• Tzorzis V, Skriapas K, Hadjigeorgiou G, Sexual dysfunction in newly diagnosed multiple sclerosis women. Mult Scler 2008;14:561-3
   PubMedGoogle Scholar
• Stenager E, Stenager EN, Jensen K. Sexual function in multiple sclerosis: a 5-year follow-up study. Ital J Neurol Sci 1996;17:67-9
   PubMedGoogle Scholar
• Nortvedt MW, Riise T, Frugard, Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007;13:106-12
   PubMed Web of Science ®Google Scholar
• Mattson D, Petrie M, Srivastava DK, Multiple sclerosis. Sexual dysfunction and its response to medications. Arch Neurol 1995;52:862-8
   PubMed Web of Science ®Google Scholar
• Fletcher SG, Castro-Borrero W, Remington G, Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 2009;6:96-107
   PubMedGoogle Scholar
• Hulter BM, Lundberg PO. Sexual function in women with advanced multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:83-6
   PubMed Web of Science ®Google Scholar
• Zivadinov R, Zorzon M, Locatelli L, Sexual dysfunction in multiple sclerosis: a MRI, neuropsychological and urodynamic study. J Neurol Sci 2003;210:73-6
   PubMed Web of Science ®Google Scholar
• Janardhan V, Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol 2000;57:1485-91
   PubMed Web of Science ®Google Scholar
• McCabe MP. Exacerbation of symptoms among people with multiple sclerosis patients: impact on sexuality and relationships over time. Arch Sex Behav 2004;33:593-601
   PubMed Web of Science ®Google Scholar
• Valleroy ML, Kraft GH. Sexual dysfunction in multiple sclerosis. Arch Phys Med Rehabil 1984;65:125-8
   PubMed Web of Science ®Google Scholar
• Betts CD, Jones SJ, Fowler CG, Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition. Brain 1994;117:1303-10
   PubMed Web of Science ®Google Scholar
• Zivadinov R, Zorzon M, Bosco A, Sexual dysfunction in multiple sclerosis: II. correlation analysis. Mult Scler 1999;5:428-31
   PubMed Web of Science ®Google Scholar
• Barak Y, Achiron A, Elizur A, Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates. J Psychiatry Neurosci 1996;21:255-8
   PubMed Web of Science ®Google Scholar
• Haggiag S, Ricci G, Bolla G, Gender differences in sexual dysfunction among a Multiple Sclerosis population. J Neurol 2010;257:S75
   Google Scholar
• Tsertsvadze A, Fink S, Yazdi F, Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med 2009;151:650-61
   PubMed Web of Science ®Google Scholar
• Fowler CJ, Miller JR, Sharief MK, A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:700-5
   PubMed Web of Science ®Google Scholar
• Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J Urol 2009;181:252-8
   PubMedGoogle Scholar
• Lombardi G, Macchiarella A, Del Popolo G. Efficacy and safety of Tadalafil for erectile dysfunction in patients with multiple sclerosis. J Sex Med 2010;7:2192-200
   PubMedGoogle Scholar
• Denil J. Ohl DA, Smythe C. Vacuum erection device in spinal cord injured men: patients and partner satisfaction. Arch Phys Rehabilit 1996;77:750-3
   PubMed Web of Science ®Google Scholar
• Dasgupta R, Wiseman OJ, Kanabar G, Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol 2004;171:1189-93
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Reis RB, Kohn IJ, Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999;53:481-6
   PubMed Web of Science ®Google Scholar
• Caruso S, Intellisano G, Lupo L, Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. Br J Obstet Gynaecol 2001;108:623-8
   Google Scholar
• Kenner M, Menon U, Elliott DG. Multiple sclerosis as a painful disease. Int Rev Neurobiol 2007;79:303-21
   PubMed Web of Science ®Google Scholar
• O'Connor AB, Schwid SR, Herrmann DN, Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 2008;137:96-111
   PubMed Web of Science ®Google Scholar
• Nurmikko TJ, Gupta S, Maclver K. Multiple sclerosis-related central pain disorders. Curr Pain Headache Rep 2010;14:189-95
   PubMed Web of Science ®Google Scholar
• Osterberg A, Boivie J. Central pain in multiple sclerosis - sensory abnormalities. Eur J Pain 2010;14:104-10
   PubMed Web of Science ®Google Scholar
• Kalia LV, O'Connor PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 2005;11:322-7
   PubMed Web of Science ®Google Scholar
• Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005;114:473-81
   PubMed Web of Science ®Google Scholar
• Ehde DM, Gibbons LE, Chwastiak L, Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler 2003;9:605-11
   PubMed Web of Science ®Google Scholar
• Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis: prevalence and clinical characteristics. Eur J Pain 2005;9:531-42
   PubMed Web of Science ®Google Scholar
• Cruccu G, Biasiotta A, Di Rezze S, Trigeminal neuralgia and pain related to multiple sclerosis. Pain 2009;143:186-91
   PubMed Web of Science ®Google Scholar
• Solaro C, Brichetto G, Amato MP, The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004;63:919-21
   PubMed Web of Science ®Google Scholar
• Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995;45:1294-6
   PubMed Web of Science ®Google Scholar
• Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol 1990;27:89-95
   PubMed Web of Science ®Google Scholar
• De Simone R, Marano E, Brescia Morra V, A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis. Neurol Sci 2005;26(Suppl 2):150-1
   Google Scholar
• Matthews WB. Paroxysmal symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 1975;38:617-23
   PubMed Web of Science ®Google Scholar
• Spissu A, Cannas A, Ferrigno P, Anatomic correlates of painful tonic spasms in multiple sclerosis. Mov Disord 1999;14:331-5
   PubMed Web of Science ®Google Scholar
• Restivo DA, Tinazzi M, Patti F, Botulinum toxin treatment of painful tonic spasms in multiple sclerosis, Neurology 2003;61:719-20
   PubMed Web of Science ®Google Scholar
• Solaro C, Tanganelli P, Messmer Uccelli M. Pharmacological treatment of pain in multiple sclerosis. Expert Rev Neurother 2007;7:1165-74
   PubMedGoogle Scholar
• Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-19
   PubMed Web of Science ®Google Scholar
• Breuer B, Pappagallo M, Knotkova H, A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther 2007;29:2022-30
   PubMed Web of Science ®Google Scholar
• Ardid D, Lamberty Y, Alloui A, Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats. Eur J Pharmacol 2003;473:27-33
   PubMed Web of Science ®Google Scholar
• Guay DR. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. Am J Geriatr Pharmacother 2003;1:18-37
   PubMedGoogle Scholar
• Rowbotham MC, Manville NS, Ren J. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia. Neurology 2003;61:866-7
   PubMed Web of Science ®Google Scholar
• Price MJ. Levetiracetam in the treatment of neuropathic pain: three case studies. Clin J Pain 2004;20:33-6
   PubMed Web of Science ®Google Scholar
• Enggaard TP, Klitgaard NA, Sindrup SH. Specific effect of levetiracetam in experimental human pain models. Eur J Pain 2006;10:193-8
   PubMed Web of Science ®Google Scholar
• Archer DP, Lamberty Y, Wang B, Levetiracetam reduces anesthetic-induced hyperalgesia in rats. Anesth Analg 2007;104:180-5
   PubMed Web of Science ®Google Scholar
• Rossi S, Mataluni G, Codeca C, Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. Eur J Neurol 2009;16:360-6
   PubMed Web of Science ®Google Scholar
• Centonze D, Mori F, Koch G, Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurol Sci 2009;30:531-4
   PubMed Web of Science ®Google Scholar
• Fregni F, Freedman S, Pascual-Leone A. Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques. Lancet Neurol 2007;6:188-91
   PubMed Web of Science ®Google Scholar
• Boggio PS, Zaghi S, Lopes M, Fregni F. Modulatory effects of anodal transcranial direct current stimulation on perception and pain thresholds in healthy volunteers. Eur J Neurol 2008;15:1124-30
   PubMed Web of Science ®Google Scholar
• Fregni F, Gimenes R, Valle AC, A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 2006;54:3988-98
   PubMed Web of Science ®Google Scholar
• Rosen AC, Ramkumar M, Nguyen T, Hoeft F. Noninvasive transcranial brain stimulation and pain. Curr Pain Headache Rep 2009;13:12-17
   PubMed Web of Science ®Google Scholar
• Knotkova H, Cruciani RA. Non-invasive transcranial direct current stimulation for the study and treatment of neuropathic pain. Methods Mol Biol 2010;617:505-15
   PubMedGoogle Scholar
• Mori F, Codeca C, Kusayanagi H, Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. J Pain 2010;11:436-42
   PubMed Web of Science ®Google Scholar
• Centonze D, Koch G, Versace V, Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology 2007;68:1045-50
   PubMed Web of Science ®Google Scholar
• Mori F, Codeca C, Kusayanagi H, Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. Eur J Neurol 2010;17:295-300
   PubMed Web of Science ®Google Scholar
• Chitsaz A, Janghorbani M, Shaygannejad V, Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation. Clin J Pain 2009;25:281-5
   PubMed Web of Science ®Google Scholar
• Solaro C, Boehmker M, Tanganelli P. Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. J Neurol 2009;256:1773-34
   PubMed Web of Science ®Google Scholar